SCHEMBL13620929

SCHEMBL13620929

Cc1ccc(OC(=O)c2ccc(OC(F)F)c3oc4ccc([N+](=O)[O-])cc4c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE4D Q08499 2/20 0.40
KMT2A Q03164 6/20 0.39
MEN1 O00255 5/20 0.39
HTT P42858 4/20 0.39
MAPK1 P28482 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GAA P10253 4/20 0.38
GLA P06280 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
LMNA P02545 3/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
TBXA2R P21731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8267950 0.94 KMT2A (0.43) MAPTALDH1A1KDM4EPDE4DKMT2A
SCHEMBL1301737 0.83 MAOA (0.43) MAPTALDH1A1PDE4DKMT2AMEN1
SCHEMBL13620937 0.83 PDE4D (0.46) MAPTALDH1A1PDE4DKMT2AMEN1
SCHEMBL73037 0.82 PDE4D (0.54) MAPTALDH1A1KDM4EPDE4DKMT2A
SCHEMBL73947 0.81 PDE4D (0.42) MAPTALDH1A1KDM4EPDE4DKMT2A
SCHEMBL5799497 0.80 RXFP1 (0.43) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL13233350 0.79 PDE4B (0.55) MAPTALDH1A1KDM4EPDE4DKMT2A
SCHEMBL5799631 0.79 MAPT (0.45) MAPTALDH1A1PDE4DKMT2AMEN1
SCHEMBL4491054 0.76 MAPT (0.38) MAPTALDH1A1KDM4EKMT2AMEN1
SCHEMBL4491052 0.76 MAPT (0.38) MAPTALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281146-A1 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE GLENMARK PHARMACEUTICALS, S.A. (CH) 2009-11-12 US disclosed
US-7563900-B2 Process for the preparation N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide GLENMARK PHARMACEUTICALS S.A. (CH) 2009-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281146-A1 PROCESS FOR THE PREPARATION OF N-(3,5-DICHLOROPYRID-4-YL)-4-DIFLUOROMETHOXY-8-METHANESULFONAMIDO-DIBENZO[B,D]FURAN-1-CARBOXAMIDE DHODH, QDPR, DPYD MAPT 4121/4885ALDH1A1 844/4885KDM4E 799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.